Contribution: Industrial Research Assistance Program – Contributions to Firms
CanBiocin Inc.
$73,000.00
Species-specific Probiotic Tolerance to High Pressure and Temperature for Broader Inclusion in Animal Feed Products
EF 2022-23 · 2022-10-03
Résumé
The proposed project addresses a major barrier to incorporating beneficial probiotic bacteria more widely into animal feed products, which is their ability to survive sterilization conditions during manufacturing. Project aims to develop product specific encapsulation formulations to increase heat and/or pressure tolerance of probiotic bacteria during industrial manufacturing conditions.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Edmonton|Edmonton, Alberta, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
877112425
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2023-09-30
Agreement Number
998083
Agreement Start Date
2022-10-03
Agreement Title
Species-specific Probiotic Tolerance to High Pressure and Temperature for Broader Inclusion in Animal Feed Products
Agreement Title (French)
Tolérance des probiotiques spécifiques à une espèce à la haute pression et à la température pour une plus grande inclusion dans les produits d’alimentation animale
Agreement Type
Contribution
Agreement Value
$73,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The proposed project addresses a major barrier to incorporating beneficial probiotic bacteria more widely into animal feed products, which is their ability to survive sterilization conditions during manufacturing. Project aims to develop product specific encapsulation formulations to increase heat and/or pressure tolerance of probiotic bacteria during industrial manufacturing conditions.
Description (French)
Le projet proposé s’attaque à un obstacle majeur à l’incorporation plus large de bactéries probiotiques bénéfiques dans les produits d’alimentation animale, à savoir leur capacité à survivre aux conditions de stérilisation pendant la fabrication. Le projet vise à développer des formulations d’encapsulation spécifiques aux produits pour augmenter la tolérance à la chaleur ou à la pression des bactéries probiotiques dans des conditions de fabrication industrielle.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Centre
Federal Riding (French)
Edmonton-Centre
Federal Riding Number
48014
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
877112425
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
CanBiocin Inc.
Recipient Postal Code
T5J 4P6
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2022-2023-Q3-998083
